News

Monday 19 October, 7.00am NZDT, Weta Uncorked, Auckland, New Zealand

MRDR report for belantamab mafodotin submitted to Pharmaceutical Benefits Advisory Committee (PBAC) public call.

Myeloma Australia Medical and Scientific Advisory Group (MSAG) Meeting - 1-2 May 2026

The MRDR has now surpassed an exciting milestone of over 9,000 registered patients.

MRDR report for belantamab mafodotin submitted to Pharmaceutical Benefits Advisory Committee (PBAC) public call.

Three manuscripts using MRDR data have been published

The recording of the meeting is now available to view.

Come find our presentations at Blood/ISBT 2025

Welcome to the Prince of Wales Hospital as a new site to the MRDR Registry.

Register now for the MRDR Annual Breakfast Meeting at Blood 2025!